# A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

> **NCT00717314** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 87 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Mycophenolate mofetil
- **DRUG:** CNI (50%)
- **DRUG:** CNI (≥75%)

## Key facts

- **NCT ID:** NCT00717314
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2014-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717314, "A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00717314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*